Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Evidence for allograft rejection in an islet transplant recipient and effect on beta-cell secretory capacity.

Rickels MR, Kamoun M, Kearns J, Markmann JF, Naji A.

J Clin Endocrinol Metab. 2007 Jul;92(7):2410-4. Epub 2007 May 8.

PMID:
17488791
2.

{beta}-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplants.

Rickels MR, Mueller R, Teff KL, Naji A.

J Clin Endocrinol Metab. 2010 Mar;95(3):1238-46. doi: 10.1210/jc.2009-2289. Epub 2010 Jan 22.

3.
4.

De Novo Donor-Specific HLA Antibodies Are Associated With Rapid Loss of Graft Function Following Islet Transplantation in Type 1 Diabetes.

Brooks AM, Carter V, Liew A, Marshall H, Aldibbiat A, Sheerin NS, Manas DM, White SA, Shaw JA.

Am J Transplant. 2015 Dec;15(12):3239-46. doi: 10.1111/ajt.13407. Epub 2015 Jul 30.

5.

HLA class I sensitization in islet transplant recipients: report from the Collaborative Islet Transplant Registry.

Naziruddin B, Wease S, Stablein D, Barton FB, Berney T, Rickels MR, Alejandro R.

Cell Transplant. 2012;21(5):901-8. doi: 10.3727/096368911X612468. Epub 2011 Nov 11.

6.

Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients.

Rickels MR, Mueller R, Markmann JF, Naji A.

J Clin Endocrinol Metab. 2009 Jan;94(1):181-9. doi: 10.1210/jc.2008-1806. Epub 2008 Oct 28.

7.

Evidence for humoral rejection of a pancreatic islet graft and rescue with rituximab and IV immunoglobulin therapy.

Kessler L, Parissiadis A, Bayle F, Moreau F, Pinget M, Froelich N, Cazenave JP, Berney T, Benhamou PY, Hanau D; GRAGIL Study Group..

Am J Transplant. 2009 Aug;9(8):1961-6. doi: 10.1111/j.1600-6143.2009.02711.x. Epub 2009 Jun 12.

8.

Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients.

Scharp DW, Lacy PE, Santiago JV, McCullough CS, Weide LG, Boyle PJ, Falqui L, Marchetti P, Ricordi C, Gingerich RL, et al.

Transplantation. 1991 Jan;51(1):76-85.

PMID:
1987709
9.

Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.

Christensen UB, Larsen PM, Fey S, Karlsen AE, Pociot F, Nerup J, Sparre T.

Autoimmunity. 2006 Jun;39(4):315-21.

PMID:
16891220
10.

Alpha-1-antitrypsin for the improvement of autoimmunity and allograft rejection in beta cell transplantation.

Ye J, Liao YT, Jian YQ, Zhang XD, Wei P, Qi H, Deng CY, Li FR.

Immunol Lett. 2013 Feb;150(1-2):61-8. doi: 10.1016/j.imlet.2013.01.009. Epub 2013 Jan 16.

PMID:
23333354
11.

Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft.

Keymeulen B, Ling Z, Gorus FK, Delvaux G, Bouwens L, Grupping A, Hendrieckx C, Pipeleers-Marichal M, Van Schravendijk C, Salmela K, Pipeleers DG.

Diabetologia. 1998 Apr;41(4):452-9.

PMID:
9562350
12.

Species incompatibilities in the pig-to-macaque islet xenotransplant model affect transplant outcome: a comparison with allotransplantation.

Graham ML, Bellin MD, Papas KK, Hering BJ, Schuurman HJ.

Xenotransplantation. 2011 Nov-Dec;18(6):328-42. doi: 10.1111/j.1399-3089.2011.00676.x.

PMID:
22168140
13.

Early metabolic markers that anticipate loss of insulin independence in type 1 diabetic islet allograft recipients.

Hirsch D, Odorico J, Danobeitia JS, Alejandro R, Rickels MR, Hanson M, Radke N, Baidal D, Hullett D, Naji A, Ricordi C, Kaufman D, Fernandez L.

Am J Transplant. 2012 May;12(5):1275-89. doi: 10.1111/j.1600-6143.2011.03947.x. Epub 2012 Feb 2.

14.

Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol.

Rickels MR, Liu C, Shlansky-Goldberg RD, Soleimanpour SA, Vivek K, Kamoun M, Min Z, Markmann E, Palangian M, Dalton-Bakes C, Fuller C, Chiou AJ, Barker CF, Luning Prak ET, Naji A.

Diabetes. 2013 Aug;62(8):2890-7. doi: 10.2337/db12-1802. Epub 2013 Apr 29.

15.

HLA sensitization in islet transplantation.

Rickels MR, Kearns J, Markmann E, Palanjian M, Markmann JF, Naji A, Kamoun M.

Clin Transpl. 2006:413-20.

16.

A significant role for histocompatibility in human islet transplantation.

Mohanakumar T, Narayanan K, Desai N, Ramachandran S, Shenoy S, Jendrisak M, Susskind BM, Olack B, Benshoff N, Phelan DL, Brennan DC, Fernandez LA, Odorico JS, Polonsky KS.

Transplantation. 2006 Jul 27;82(2):180-7.

PMID:
16858280
17.

Development of anti-human leukocyte antigen class 1 antibodies following allogeneic islet cell transplantation.

Lobo PI, Spencer C, Simmons WD, Hagspiel KD, Angle JF, Deng S, Markmann J, Naji A, Kirk SE, Pruett T, Brayman KL.

Transplant Proc. 2005 Oct;37(8):3438-40.

PMID:
16298621
18.

Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.

Goss JA, Schock AP, Brunicardi FC, Goodpastor SE, Garber AJ, Soltes G, Barth M, Froud T, Alejandro R, Ricordi C.

Transplantation. 2002 Dec 27;74(12):1761-6.

PMID:
12499894
19.

Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass.

Teuscher AU, Kendall DM, Smets YF, Leone JP, Sutherland DE, Robertson RP.

Diabetes. 1998 Mar;47(3):324-30.

PMID:
9519735
20.

Metabolic function of a suboptimal transplanted islet mass in nonhuman primates on rapamycin monotherapy.

Soleimanpour SA, Hirshberg B, Bunnell DJ, Sumner AE, Ader M, Remaley AT, Rother KI, Rickels MR, Harlan DM.

Cell Transplant. 2012;21(6):1297-304. doi: 10.3727/096368911X603620. Epub 2011 Nov 11.

Supplemental Content

Support Center